Cargando…
Retrospective analysis of 426 donors of a convalescent collective after mild COVID-19
BACKGROUND: The novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread across the world. The aim of our study was to characterize mild courses and to determine the antibody status for these patients. METHODS: We initiated an...
Autores principales: | Flieder, Tobias, Vollmer, Tanja, Müller, Benjamin, Dreier, Jens, Fischer, Bastian, Knabbe, Cornelius, Birschmann, Ingvild |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7901786/ https://www.ncbi.nlm.nih.gov/pubmed/33621254 http://dx.doi.org/10.1371/journal.pone.0247665 |
Ejemplares similares
-
Humoral and cellular immune response levels at a 1-year follow-up after mild COVID-19
por: Flieder, Tobias, et al.
Publicado: (2022) -
Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
por: Fischer, Bastian, et al.
Publicado: (2021) -
Strain-dependent interactions of Streptococcus gallolyticus subsp. gallolyticus with human blood cells
por: Grimm, Imke, et al.
Publicado: (2017) -
Retrospective study shows that early administration of convalescent plasma in hospitalized COVID‐19 patients may have a positive effect on disease progression
por: Birschmann, Ingvild, et al.
Publicado: (2022) -
Hepatitis E in blood donors: investigation of the natural course of asymptomatic infection, Germany, 2011
por: Vollmer, Tanja, et al.
Publicado: (2016)